Pacific Biosciences of California, Inc. Earnings Per Share (Basic)
Pacific Biosciences of California, Inc. (PACB) reported Earnings Per Share (Basic) of -$0.14 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Pacific Biosciences of California, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.14.
- Pacific Biosciences of California, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.03.
- Pacific Biosciences of California, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.13, a 1696.29% decline year-over-year.
- Pacific Biosciences of California, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.13.
- Pacific Biosciences of California, Inc. earnings per share, basic for fiscal 2025 was -$1.82.
- Pacific Biosciences of California, Inc. earnings per share, basic for fiscal 2024 was -$1.13.
- Pacific Biosciences of California, Inc. earnings per share, basic for fiscal 2023 was -$1.21.
- Pacific Biosciences of California, Inc. earnings per share, basic for fiscal 2022 was -$1.40.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.14 10-Q · filed 2026-08-06 | -$0.17 10-Q · filed 2026-08-06 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.03 10-Q · filed 2026-05-08 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.82 10-K · filed 2026-02-25 |
| 2025-09-30 | -$0.13 10-Q · filed 2025-11-06 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.69 10-Q · filed 2025-11-06 | -$1.71 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.14 10-Q · filed 2026-08-06 | -$1.57 10-Q · filed 2026-08-06 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.83 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$1.44 10-Q · filed 2026-05-08 | -$1.46 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$2.34 derived: net income ÷ weighted average shares · filed 2026-05-08 |
| 2024-12-31 | $0.01 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$1.13 10-K · filed 2026-02-25 |
| 2024-09-30 | -$0.22 10-Q · filed 2025-11-06 | -$0.86 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.15 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$0.64 10-Q · filed 2025-08-07 | -$0.93 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.29 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$1.21 10-K · filed 2026-02-25 | |||
| 2023-09-30 | -$0.26 10-Q · filed 2024-11-12 | -$0.90 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$0.28 10-Q · filed 2024-08-09 | -$0.64 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | -$0.36 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.40 10-K · filed 2025-03-17 | |||
| 2022-09-30 | -$0.34 10-Q · filed 2023-11-03 | -$1.03 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | -$0.32 10-Q · filed 2023-08-04 | -$0.68 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | -$0.37 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$0.89 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $0.08 10-Q · filed 2022-11-08 | -$0.56 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$0.21 10-Q · filed 2022-08-08 | -$0.65 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$0.45 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $0.18 10-K · filed 2023-02-28 | |||
| 2020-09-30 | -$0.14 10-Q · filed 2021-11-05 | -$0.29 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | -$0.15 10-Q · filed 2021-08-06 | -$0.14 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $0.01 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$0.55 10-K · filed 2022-02-28 | |||
| 2019-03-31 | -$0.20 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | -$0.76 10-K · filed 2021-02-26 | |||
| 2016-09-30 | -$0.19 10-Q · filed 2016-11-04 | -$0.63 10-Q · filed 2016-11-04 | ||
| 2015-09-30 | $0.02 10-Q · filed 2016-11-04 | -$0.41 10-Q · filed 2016-11-04 | ||
| 2014-09-30 | -$0.13 10-Q · filed 2015-11-05 | -$0.68 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |